A study on hepatocellular carcinoma found that TIM-3+ TIGIT+ CD8+ T cells were associated with the rate of progression and poor prognosis of patients with hepatocellular carcinoma [29]. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.